To require enforcement against misbranded egg alternatives.
Summary
What This Bill Does
Bars foods intended as substitutes or alternatives for eggs or egg products from using egg market names unless they meet statutory criteria, directs FDA enforcement guidance and reporting, and preserves shape-based uses of egg terminology that are not substitute claims.
Who Benefits and How
Consumers and traditional egg producers could benefit from tighter labeling rules aimed at substitute egg alternatives while preserving limited descriptive uses that do not market a product as an egg substitute.
Who Bears the Burden and How
Manufacturers of egg substitutes could face stricter labeling and enforcement risk, and FDA would have to issue guidance, enforce the new standard, and report to Congress.
Key Provisions
- States findings about eggs' nutritional value and the risk of misleading labeling of egg alternatives.
- Bars foods using egg market names as substitutes or alternatives from interstate commerce unless they satisfy the statutory egg or egg-product criteria.
- Defines egg, egg product, and egg market names for misbranding purposes and preserves shape-based descriptive uses that are not substitute representations.
- Requires FDA draft and final guidance, nullifies inconsistent guidance, and requires a congressional enforcement report.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Bars foods intended as substitutes or alternatives for eggs or egg products from using egg market names unless they meet statutory criteria, directs FDA enforcement guidance and reporting, and preserves shape-based uses of egg terminology that are not substitute claims.
Key Policy Areas
Food Regulation, Agriculture, Consumer Protection
Primary Purpose
Bars foods intended as substitutes or alternatives for eggs or egg products from using egg market names unless they meet statutory criteria, directs FDA enforcement guidance and reporting, and preserves shape-based uses of egg terminology that are not substitute claims.
Policy Domains
Main Provisions
Identified Gains
Contextual inference, no direct clause citation- Consumers and traditional egg producers seeking tighter enforcement against mislabeled egg substitutes
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Manufacturers of egg substitutes and FDA officials enforcing the new labeling rules
Contextual inference, no direct clause citation
Sponsors
John Fetterman
D-PA | Primary Sponsor
Legislative Progress
IntroducedMr. Fetterman (for himself and Ms. Ernst) introduced the following …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Manufacturers of egg substitute or alternative products using egg-related market names
Consumers seeking clearer distinction between eggs and substitutes
FDA officials issuing guidance, enforcing the standard, and reporting to Congress
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary"
- → Secretary of Health and Human Services
- "commissioner"
- → Commissioner of Food and Drugs
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology